LFF
MRNA icon

Level Four Financial’s Moderna MRNA Stock Holding History

Level Four Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$766K Buy
1,991
+925
+87% +$341K 0.33% 76
2021
Q2 		$250K Buy
+1,066
New +$191K 0.11% 247

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Level Four Financial's MRNA Position: Q3 2021 in Review

Level Four Financial increased its Moderna (MRNA) stake by 87% in Q3 2021, buying an estimated $341K and bringing the position to 1,991 shares worth $766K. The position accounts for 0.33% of the portfolio, ranked #76.

Level Four Financial first reported a position in MRNA in Q2 2021 and has held it in 2 quarters since. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Level Four Financial held 1,991 shares of Moderna worth $766K as of Q3 2021.
  • Level Four Financial bought 925 Moderna shares in Q3 2021, an estimated $341K.
  • Moderna made up 0.33% of Level Four Financial's portfolio in Q3 2021, its #76 holding.
  • Level Four Financial first reported a position in Moderna in Q2 2021 and has held it in 2 quarters since.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.